Clinical trials in Brugge – page 5

217 clinical trials in Brugge, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Brugge at a glance

217

clinical trials

Research sites1

Quick filters

217 trials in Brugge

Open in trial search

Myocardial infarction

Recruiting

Study on Prasugrel and Acetylsalicylic Acid for Patients with ST-Elevated Myocardial Infarction Undergoing Different Revascularization Techniques

Registered drugNo placebo

Study on Prasugrel and Acetylsalicylic Acid for Patients with ST-Elevated Myocardial Infarction Undergoing Different Revascularization Techniques

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Research Maatschap Cardiologen Rotterdam Zuid

Contact Research Centre

Mantle cell lymphoma

Recruiting

Study on Glofitamab, Venetoclax, and Zanubrutinib for Patients with Untreated or Relapsed High-Risk Mantle Cell Lymphoma

Registered drugNo placebo

Study on Glofitamab, Venetoclax, and Zanubrutinib for Patients with Untreated or Relapsed High-Risk Mantle Cell Lymphoma

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Glofitamab
Sponsor:LYSARC

Contact Research Centre

Plasma cell myeloma

Recruiting

Study Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo

Study Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Bortezomib
Sponsor:Pfizer Inc.

Contact Research Centre

Atrial fibrillation+3

Recruiting

Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

Registered drugNo placebo

Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Insel Gruppe AG

Contact Research Centre

Psoriasis

Recruiting

Study on Proactive Drug Monitoring with Secukinumab, Ixekizumab, or Guselkumab for Patients with Moderate-to-Severe Psoriasis

Registered drugNo placebo

Study on Proactive Drug Monitoring with Secukinumab, Ixekizumab, or Guselkumab for Patients with Moderate-to-Severe Psoriasis

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Guselkumab
Sponsor:Universitair Ziekenhuis Gent

Contact Research Centre

Myelofibrosis+1

Recruiting

Study on Long-Term Safety of Pelabresib for Patients with Myelofibrosis or Essential Thrombocythemia

InvestigationalNo placebo

Study on Long-Term Safety of Pelabresib for Patients with Myelofibrosis or Essential Thrombocythemia

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:2-((4S)-6-(4-Chlorophenyl)-1-Methyl-4H-Benzo[C]Isoxazolo[4,5-E]Azepin-4-Yl)Acetamide Monohydrate
Sponsor:Novartis Pharma AG

Contact Research Centre

Ductal adenocarcinoma of pancreas

Recruiting

Study of fluorouracil, irinotecan and oxaliplatin combination therapy for patients with metastatic pancreatic ductal adenocarcinoma who progressed after gemcitabine treatment

Registered drugNo placebo

Study of fluorouracil, irinotecan and oxaliplatin combination therapy for patients with metastatic pancreatic ductal adenocarcinoma who progressed after gemcitabine treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Fluorouracil
Sponsor:Groupe Belge D'Oncologie Digestive

Contact Research Centre

B-cell lymphoma+1

Recruiting

Study of valemetostat tosylate tablets in patients with relapsed or refractory B-cell lymphoma, including aggressive B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and Hodgkin lymphoma

InvestigationalNo placebo

Study of valemetostat tosylate tablets in patients with relapsed or refractory B-cell lymphoma, including aggressive B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and Hodgkin lymphoma

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Valemetostat Tosilate
Sponsor:LYSARC

Contact Research Centre

Epstein-Barr virus associated lymphoproliferative disorder

Recruiting

Study on Tabelecleucel for Patients with Epstein-Barr Virus-Associated Diseases

InvestigationalNo placebo

Study on Tabelecleucel for Patients with Epstein-Barr Virus-Associated Diseases

InvestigationalNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Tabelecleucel
Sponsor:Pierre Fabre Medicament

Contact Research Centre

Infantile apnoea

Recruiting

Study on Doxapram for Treating Apnea in Preterm Newborns

Investigational

Study on Doxapram for Treating Apnea in Preterm Newborns

Investigational

Belgium

Participants:0–17 years
Substances:Doxapram Hydrochloride Monohydrate
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Small intestine adenocarcinoma

Recruiting

Study on the Effectiveness of Fluorouracil, Levoleucovorin, and Oxaliplatin in Patients with Resected Small Bowel Adenocarcinoma

Registered drugNo placebo

Study on the Effectiveness of Fluorouracil, Levoleucovorin, and Oxaliplatin in Patients with Resected Small Bowel Adenocarcinoma

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Groupe Belge D'Oncologie Digestive

Contact Research Centre

Craniocerebral injury

Recruiting

Study on the Effects of Ketamine on Therapy Intensity and Brain Pressure in Patients with Traumatic Brain Injury

Registered drug

Study on the Effects of Ketamine on Therapy Intensity and Brain Pressure in Patients with Traumatic Brain Injury

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Ketamine
Sponsor:UZ Leuven

Contact Research Centre

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Brugge

What the registry says about research in the country

01 Infectious Diseases

Clinical studies focusing on viral infections and preventive measures, including trials evaluating new vaccines against influenza and cytomegalovirus. Research also covers treatment approaches for hepatitis B and invasive fungal infections.

Influenza vaccine efficacy studies
CMV prevention research
Antifungal treatments

Innovative approaches in vaccine development and antimicrobial therapies are being tested to combat various infectious diseases.

02 Oncology & Hematology

Comprehensive research into blood cancers and solid tumors, including studies on multiple myeloma, leukemia, and gastric cancer. Novel therapeutic approaches combine targeted treatments with immunotherapy.

Blood cancer treatments
Gastric cancer therapies
Lymphoma management

Advanced treatment protocols are being evaluated to improve patient outcomes in various cancer types.

03 Cardiovascular & Metabolic Disorders

Studies addressing cardiovascular disease, obesity, and type 2 diabetes. Research focuses on innovative treatments and prevention strategies for major cardiovascular events.

Cardiovascular risk reduction
Metabolic disease management
Obesity interventions

Trials aim to improve cardiovascular outcomes and metabolic health through novel therapeutic approaches.

Back to Belgium All countries